MRD / Regn No. : 20260000113 Date : 10/06/2026
Patient Name : Suchismita Bannerjee Age & Gender : 56 Yrs. / Female
Contact No. : 9874896373 UHID :
Ht / Wt / BMI : 150 / 77 / 34.22 BP S / BP D : 123 / 77
Allergies : NKA Referred By :
   
Problem List : TYPE 2 DM (21/Feb/2017) | OBESITY (21/Feb/2015) | NAFLD (21/Feb/2026) | VITAMIN D INSUFFICIENCY (21/Feb/2026) |
Subjective : T2DM SINCE 2017,DYSLIPIDEMIA,NAFLD,HYPERURICEMIA,RECURRENT UTI,HAS CONSTIPATION
Objective : NONE
Analysis : OBESITY,T2DM,S3F0 MASLD
Plan : CONTINUE CURRENT MEDICATIONS,SEE ME IN 2 MONTHS  
Salient Investigations : FASTING PLASMA GLUCOSE (FPG): 104 mg/dL | GLYCOSYLATED HEMOGLOBIN (HBA1C): 6.7 % | POST PRANDIAL GLUCOSE (2HPP): 108 mg/dL
S# Generic (Trade) Name Route Dosage Usage Duration
1 SGLT2I EMPAGLIFLOZIN 10 MG
JARDIANCE
Medicine For DIABETES OBESITY HEART AND KIDNEY PROTECTION
PO 1-0-0 BEFORE FOOD
TILL NEXT VISIT
MAY CAUSE GENITOURINARY INFECTIONS
2 CAPSULE CHOLECALCIFEROL 2000 IU
D RISE
Medicine For VITAMIN D
PO 0-0-1 AT BEDTIME
TILL NEXT VISIT
3 TELMISARTAN 40 MG
ERITEL 40 MG
0-0-1 AT BEDTIME
TILL NEXT VISIT
MAY CAUSE HIGH POTASSIUM
4 ROSUVASTATIN 10 MG
ROSEDAY 10 MG
Medicine For CHOLESTEROL
PO 0-0-1 AT BEDTIME
TILL NEXT VISIT
MAY CAUSE FATIGUE AND MUSCLE PAIN
5 SODIUM PICOSULFATE 10 MG
CREMLAX 10 MG
0-0-1 BEFORE FOOD
TILL NEXT VISIT
6 INJECTION SEMAGLUTIDE 1 MG
OZEMPIC
Medicine For OBESITY DIABETES
SQ ONCE A WEEK AS DIRECTED NO RELATION TO FOOD
TILL NEXT VISIT
MAY CAUSE NAUSEA VOMITING
       
Refill : 0 / Substitution:    
Education :
Next Visit : 09/Aug/2026
Tests Suggested For Next Visit : FBS 2HPP HBA1C
   
   

Dr. Krishna G Seshadri
Sr. Consultant Endocrinology Diabetes and Metabolism
Tamil Nadu / 48748 HPRID: 71-0638-2075-7542

Disclaimer: This is an ONLINE consultation. The patient has not been physically examined. The prescription or advice is based on the patient's description of the problem which is given above and also explained over video consultation.
This is a Computer generated Prescription

Powered By: